Barak Beit Investments Ltd. (BARI)

Overview

Barak Investment House Ltd, originally known as Panaxia Labs Israel Ltd until May 2024, has established itself as a significant player in providing pharmaceutical solutions both within Israel and on a global scale. Headquartered in Lod, Israel, and founded in 2005, the company specializes in the development, production, and distribution of pharma-grade, smokeless cannabis products. These offerings are tailored to meet the needs of patients and physicians, reflecting the company's commitment to delivering innovative health solutions and advancing the pharmaceutical use of cannabis.

Products and Services

• Oral Tablets: Designed for ease of use and accurate dosing, these tablets offer a discreet and convenient option for cannabis consumption.
• Orodispersible Tablets: These tablets dissolve quickly in the mouth, providing rapid absorption and onset of effects, ideal for those requiring fast relief.
• Sublingual Tablets: Placed under the tongue for absorption, these tablets offer an alternative ingestion route for faster delivery into the bloodstream.
• Oral Oils: These oils are intended for oral ingestion, providing a flexible dosing solution that can be adjusted to meet individual patient needs.
• Sublingual Drops: Offering precise dosing and rapid absorption, these drops are applied under the tongue, ensuring quick therapeutic effects.
• Solution for Inhalation: Designed for those who prefer inhalation, this solution offers a controlled method for cannabis consumption.
• Pastilles: These small, lozenge-like products offer a discreet and portable option for cannabis intake, slowly dissolving in the mouth.
• Topicals: Applied externally, these products are designed for localized relief, catering to those seeking targeted effects without systemic exposure.
• Suppositories: Providing an alternative for those unable to use oral forms, suppositories offer direct absorption and can be particularly effective for specific conditions.
• Cannabis Extracts in Ethanol: These extracts offer a versatile ingredient for various medical cannabis applications, showcasing the company's commitment to innovation.

The product range is marketed under the brands NAXIVA – PANAXOL, NAXIVA-PANAXOL-ONKO, PANAXIR SENSE, PANAXIR, Axiban, Tikva, Ultra Health, and Salus, each designed to meet diverse patient needs and medical conditions. Through its comprehensive product suite, Barak Investment House Ltd sustains its mission to improve patient outcomes and enhance the quality of life for individuals worldwide.